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SUMMARY  Acne vulgaris is a multifactorial disease of as yet in-
completely elucidated etiology and pathogenesis. The following have 
been identified as the most significant factors: follicular hyperkerato-
sis, increased sebum secretion, Propionibacterium (P.) acnes, and 
inflammation. Increased sebum production and follicular hyperkera-
tosis result in the development of microcomedones, and changes in 
follicular milieu in intensive growth of P. acnes. P. acnes secretes sev-
eral proinflammatory products,  which play an important role in the 
development of inflammation. These include lipases, proteases, hy-
aluronidases, and chemotactic factors. Immune response to P. acnes 
includes humoral and cell-mediated immunity as well as complement 
activation. Recent results indicate that keratinocytes and sebocytes, 
as major components of  pilosebaceous unit, may act as immune 
cells and may be activated by P. acnes via toll-like receptors (TLRs) 
and CD14, and through CD1 molecules may recognize altered lipid 
content in sebum, followed by the production of inflammatory cyto-
kines.
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 INTRODUCTION
 Acne vulgaris is a multifactorial disease, which 
includes hormonal, microbial and immune mecha-
nisms. The process occurs in  pilosebaceous unit, 
resulting in microcomedo due to hyperkeratiniza-
tion and increased sebum production, and after-
wards open and closed comedo. These are non-
inflammatory acne lesions. Further process may 
result in inflammatory acne lesions, i.e. papules, 
pustules and nodules. Most patients have a mix-
ture of lesions. The lesions are localized in the so-
called acne-prone areas (cheeks, nose, forehead, 
midline chest and back). The changes occur pri-
marily in adolescents with the secretion of andro-
gen hormones, which regulate the activity of seba-
ceous glands. It is characterized  by spontaneous 
resolution at approximately age 25, although the 
hormone level remains the same. However, the 
background of this process remains unclear. A 
possible explanation for the resolution of lesions 
may lie in the follicular cycling process, similar to 
the terminal hair follicles (1,2).
 INCREASED SEBUM PRODUCTION                
 All acne patients have increased sebum pro-
duction. Sebum production is greater in patients 
with more severe acne. Sebum secretion is differ-
ent in follicles, depending on the follicle type and 
localization. It is most pronounced in so-called 
acne-prone follicles distributed in acne-prone ar-
eas. Sebaceous glands are characterized by their 
hyperresponse to androgens, which is genetically 
determined. Investigations in monozygotic twins 
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showed a significant influence of the genetic fac-
tor (3). Most patients have normal blood androgen 
levels. Skin has a cellular mechanism to convert 
testosterone into more potent dihydrotestosterone 
(DHT) in the presence of the 5α-reductase (type 1) 
enzyme. An increased activity of this enzyme was 
detected in acne-prone areas such as the face, 
correlating with other areas on the legs or hands 
(4). Antiandrogens, estrogens and retinoid, which 
decrease sebaceous gland activity, control acne 
(5). Besides increased sebum secretion, there are 
changes in the composition of lipids. The levels of 
free fatty acids, squalene and squaling oxide are 
increased, while the concentration of linoleic acid 
is lower.
 Sebum secretion is also affected by stress. Se-
baceous glands may be stimulated in a way similar 
to the hypothalamic-pituitary-adrenal (HPA) axis. 
Corticotrophin-releasing hormone (CRH) is the 
most proximal element of HPA axis and it acts on 
neuropeptide receptors stimulating lipid synthesis 
as a response to stress (6). CRH and CRH recep-
tors were detected in human sebaceous glands. 
CRH induced a biphasic increase in the synthe-
sis of sebaceous lipids and up-regulated in mRNA 
levels of 3β-hydroxysteroid dehydrogenase/δ (5-
4) isomerase, important for testosterone synthe-
sis in human sebocytes (7). The role of stress in 
acne could be related to the release of neurome-
diators such as substance P (SP), which stimu-
lates sebum production. Data from immunologic, 
physiologic and chemical studies have also shown 
that this substance is close to sebaceous gland. 
In vitro exposure of normal skin to the activity of 
this substance resulted in a significant increase in 
the size of sebaceous gland and number of sebum 
vacuoles in sebaceous cells. Recent data have 
also shown that receptors to neuromediators are 
present in sebaceous glands, e.g., SP and α-me-
lanocyte stimulating hormone (8,9).
 FOLLICULAR HYPERKERATOSIS
 Why follicular hyperkeratosis occurs remains 
largely unknown. There are several  theories. One 
of them is that there is a reduction in the amount of 
lamellar granules in stratum spinosum, secreting 
enzymes that dissolute cement substance in stra-
tum corneum, enabling their separation (10,11). 
Increased expression of tenascin, an extracellular 
matrix glycoprotein that can interact with cells and 
alter them to adhere, migrate and proliferate, has 
been associated with the development of acne le-
sion (12). Androgens regulate sebaceous gland 
function and play an important role in the develop-
ment of hyperkeratosis in infundibulum, because 
keratinocytes in infundibulum have a greater ca-
pacity to metabolize androgens (13). Other inves-
tigators have reported that a disorder in the normal 
process of keratinization in follicular channel could 
be caused by a modified lipid composition, leading 
to increased cohesion of cells in the follicle (14-
16). Cytokines, such as interleukin-1α (IL-1α), are 
an important factor that may induce proliferation 
of keratinocytes, while epidermal growth factor 
(EGF) reduces comedo formation. Comedogene-
sis was induced experimentally by IL-1α, and was 
blocked by IL-1 receptor antagonist. Cytokine IL-
1α has been found to be present in high amounts 
in noninflammatory acne lesions (17).
 PROPIONIBACTERIUM ACNES
 Propionibacterium (P.) acnes is an anaerobic 
pleomorphic diphtheroid, which normally resides 
in the follicle. Increased sebum secretion of the af-
fected follicles provides a very good environment 
for the development of this bacterium. It ingests 
sebum and dilutes  triglycerides into glycerol and 
free fatty acids, which have proinflammatory and 
comedogenic features. The usual treatment of in-
flamed acne by antibiotics decreases inflamma-
tion, however, the presence of P. acnes resistance 
to antibiotics may be associated with therapeutic 
failure. According to normal standards, P. acnes 
is not pathogenic, because it is localized in the 
follicles free from acnes, so there is minimal cor-
relation between the number of P. acnes and the 
severity of clinical signs and type of acne. P. acnes 
has been shown serologically and biochemically 
to be identical to Corynebacterium parvum, a po-
tent stimulator of the reticuloendothelial system 
(18,19).
 INFLAMMATION
 Inflammation in acne is the result of the body 
response to P. acnes. This bacterium produces 
different enzymes and chemotactic factors, at-
tracting polynuclears. Upon phagocytosis, attract-
ed polynuclears release proinflammatory media-
tors such as reactive oxygen species (ROS) and 
cytokines. ROS produced by activated neutrophils 
cause damage to the follicular wall epithelium, 
expelling the follicle content into the dermis and 
resulting in inflammation. Tetracyclines, especially 
minocycline hydrochloride, that are the first choice 
in inflamed acne treatment, inhibit the formation of 
ROS by neutrophils, thus reducing inflammation 
(20,21). 
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 Stimulation of cytokine production by P. acnes 
could be important in the pathogenesis of  inflam-
matory acne vulgaris and may have wider implica-
tions for immunomodulation  of the human system 
by commensal skin microorganisms. The mech-
anism of cytokine production remains unclear, 
however, it has been assumed to occur in several 
ways. Besides keratinocytes, which are the main 
source of cytokines in epidermis, they are also 
produced by polymorphonuclears, attracted by 
chemotactic factors of P. acnes in the follicle. 
 P. acnes hydrolyzes triglycerides to free fatty 
acids, which are toxic for the follicle wall cells. Var-
ious proinflammatory cytokines are involved, e.g., 
interleukin 1α (IL-1α), transforming growth factor α 
(TGF-α), tumor necrosis factor α (TNF-α), interfer-
on γ (INF-γ), epidermal growth factor (EGF), IL-8 
and IL-12. EGF and TGF-α cause disorganization 
of keratinocytes in the hair follicle, leading to infun-
dibular rupture and resulting in sebum entry into 
the dermis and development of inflammation. IL-
1α influences inflammatory response, stimulating 
the production of vascular endothelial growth fac-
tor in dermal papillae and follicular keratinocytes of 
pilosebaceous unit (11). IL-1 is multifunctional and 
mediates a wide spectrum of inflammatory, meta-
bolic, physiologic and immune reactions (22,23). 
IL-1 plays a central role in inflammation induction 
of inflammatory response, specific for various der-
matoses. In acne, IL-1α causes hyperkeratosis in 
hair infundibulum resulting in microcomedones and 
can be found at increased concentrations in the as 
yet noninflamed acne lesions. In vitro experiments 
showed it to be possible to induce hyperkeratosis 
in infundibulum similar to that found in comedone 
(5,17,24). The stimulus that triggers IL-1α produc-
tion by ductal keratinocytes is unknown (25). There 
is a hypothesis that the induction of IL-1α produc-
tion could be caused by a deficit of the essential 
fatty acid, linoleic acid, in the follicular wall kerati-
nocytes, found in acne (26). It is considered that 
the altered sebum content and increased rate of 
its secretion may precipitate IL-1α from keratino-
cytes in infundibulum, stimulating comedogenesis 
(12). Besides IL-1, other cytokines such as TNF-α, 
IFN-γ, EGF and TGF-α, may also be involved (7).
 The P. acnes immune response is another way 
of inflammation initiation in acne. Circulating im-
mune complexes have been reported to be elevat-
ed in some acne patients. The degree of elevation 
correlated with the severity of acne inflammation 
(18). Complement-fixing antibody titers are elevat-
ed and in correlation with the severity of inflam-
mation. They are reported to be largely of the IgG 
class (16,18). Antibodies against P. acnes may 
increase inflammation activating complements via 
classic or alternate pathways, causing the release 
of comedogenic (IL-1α), inflammatory (TNF-α and 
IFN-γ) and disruptive (TGF-α) cytokines from the 
cells of inflammatory and immune system (26). 
Activated complement may form the potent che-
moattractant C5a, which further amplifies the re-
cruitment of immune cells (27).
 The role of cell-mediated immunity is far from 
having been proven. However, skin tests done 
with common recall antigens such as trichophytin, 
mumps, or purified protein derivative have demon-
strated that patients with severe acne may have 
a depressed or absent reactivity. In addition, sen-
sitization to dinitrochlorobenzene may not occur 
(18). Heat-killed P. acnes skin test has strongest 
response in the most severe acne cases (28).
 Recent investigations have shown that micro-
bial antigens can directly influence the release of 
proinflammatory cytokines (IL-1α, TNF-α, IFN-γ, 
TGF-α), activating toll-like receptors (TLRs). Two 
mechanisms could play an important role in the 
development of inflammation in acne (16,24): 
recognition of pathogens by TLRs and CD14 re-
ceptors, and abnormal lipid presentation by CD1d 
molecule.
 Keratinocytes and sebocytes have been dem-
onstrated to play important roles in acne patho-
genesis; these are major components of piloseba-
ceous unit, which is constantly  hosting P. acnes 
and is especially rich in lipids. Keratinocytes and 
sebocytes have TLRs, CD14 and CD1d recep-
tors, although they do not belong to immune sys-
tem cells like macrophages, neutrophils, dendritic 
cells and lymphocytes. These receptors belong to 
the innate immunity and first line defense against 
pathogens. In contrast to adaptive, innate immu-
nity represents an older system of defense against 
pathogens and is activated through a limited num-
ber of antigens specific for conserved microbial 
structures. Recognition of these structures by the 
innate immune system induces  costimulators, 
cytokines, and chemokines, which recruit and 
activate antigen-specific lymphocytes and initiate 
adaptive immune response (29,30).
 TLRs  belong to a wide group of related recep-
tors called pattern recognition receptors (PRRs) 
that are specific for common constituents of 
pathogenic microorganisms. By means of TLRs, 
keratinocytes and sebocytes receive signals from 
microorganisms (bacteria, viruses and fungi), en-
abling response to infection. Toll receptors were 
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first identified in Drosophila and recent studies 
suggest that mammalian toll homologs, TLRs, 
mediate immune response to microbial ligands 
(31). Recent studies of TLRs have suggested that 
these receptors are necessary elements for the 
host defense against pathogens, activating innate 
immunity as a prerequisite for induction of adap-
tive immunity (29,32).
 PRRs recognize relatively invariant structures 
within a given class of microorganisms. These 
include various components in the bacterial cell 
wall  such as lipopolysaccharides (LPS), peptido-
glycans, lipopeptides, flagellin, and bacterial DNA. 
These components are called pathogen-associ-
ated molecular patterns (PAMPs). In PRRs, TLRs 
have the crucial role in the recognition of PAMPs, 
and they induce antimicrobial response in different 
cells. TLRs require the presence of coreceptors to 
initiate the signaling cascade (16,29,31).
 On keratinocytes and sebocytes from the 
group of TLR receptors, TLR2 and TLR4  recep-
tors are present and can be activated directly by 
P. acnes antigens. Further, the recognition of P. 
acnes by TLR is strongly induced by CD14. CD14 
is also a coreceptor necessary to initiate the sig-
naling cascade. Keratinocytes, activated in this 
way, directly produce proinflammatory cytokines, 
i.e. TNF-α, IL-1β, IL-8 and IL-12, stimulating mac-
rophages for the production of these cytokines 
(9,24). Macrophages around the pilosebaceous 
follicle in acne disease also have TLR2 receptors 
and present evidence for a mechanism mediated 
by TLR to occur at the site of disease (24).
 Two major components of the gram-positive 
cell wall, reported to induce immune response of 
keratinocytes and sebocytes by TLRs, are pep-
tidoglycan-polysaccharide  (PG-PS) complexes 
and lipoteichoic acid. It is suggested that P. acnes 
acts in a similar way (16,21,27). Stimulation of 
TLRs by PAMPs initiates a signaling cascade 
leading to the activation of the transcription factor 
NF-κB, which induces the secretion of proinflam-
matory cytokines that direct the adaptive immune 
response (23,33,34).
 CD14 is a glycosylphosphatidylinositol (GPI)-
anchored membranous protein that acts  as a bac-
terial pattern recognition receptor. CD14 is found 
in macrophages, neutrophils, B lymphocytes, ke-
ratinocytes and sebocytes. CD14 is member of 
the heteromeric lipopolysaccharide (LPS) receptor 
complex, which also contains TLR4. This receptor 
is associated with TLR4, initiating signaling. It also 
interacts with TLRs as a response to different mi-
crobial infections (23).
 CD1 molecules represent a family of nonpoly-
morphic glycoproteins, and they could function as 
“sensory” molecules, sensing alterations in cellu-
lar lipid content. CD1  molecule is expressed by 
a variety of cells: thymocytes, activated T cells, 
B lymphocytes, professional antigen-presenting 
cells, and intestinal epithelial cells. CD1d  mol-
ecule is considered to present abnormal lipids in 
sebocytes and keratinocytes from pilosebaceous 
unit, and to activate NKT cells to secrete different 
cytokines, thus developing inflammation (16).
 It is considered that leukotrienes have an im-
portant role in the development of tissue inflam-
mation. Leukotrienes belong to a family of highly 
potent biologic substances, eicosanoids, deriva-
tives of arachidonic acid (24,35). Leukotriene B4 
is a proinflammatory mediator with a key role in 
the development of tissue inflammation in acne 
as well as in other skin diseases with inflamma-
tion and hyperkeratosis, especially psoriasis. It is 
synthesized from arachidonic acid. The synthesis 
of leukotriene B4 is catalyzed by 5-lipooxygenase. 
Leukotriene B4 is a natural ligand for peroxisome 
proliferator-activated receptor α (PPARs), enabling 
the synthesis of free fatty acids (24). Zouboulis et 
al. showed the inflammation in acne to decrease 
by inhibiting the synthesis of leukotriene B4. This 
is a strong evidence that eicosanoids may play an 
important role in the development of inflammation 
in acne. These results also support the view that 
lipids induce inflammation in acne, independently 
of the presence of bacteria or increased systemic 
levels of proinflammatory molecules (35). The ad-
ministration of a specific inhibitor, 5-lypooxygen-
ase, resulted in reduced inflammation, significant 
reduction in total lipids and especially in free fatty 
acids in sebum. Among several diseases, hyper-
keratotic inflammatory skin diseases and espe-
cially psoriasis seem to respond to this therapy. 
Using this therapy, reduction of inflammation is 
greater than with local or oral antibiotics (clinda-
mycin, erythromycin) (24,35).
 It is known that biologic activity of retinoids 
on the skin occurs via specific nuclear receptors, 
retinoic acid receptors (RARs) (36-38). The favor-
able activity of locally applied retinoids in acne oc-
curs through down-regulation of the expression of 
TLRs, receptors involved in P. acnes recognition 
(16,35,39). Retinoids reduce the activation of AP-
1 by reducing the increase of collagenase in the 
dermis, and prevent decomposition of collagens, 
thus diminishing the possibility of scar formation in 
acne (38,40,41).
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CONCLUSION  
 Several factors are involved in the pathogen-
esis of acne: seborrhea, follicular hyperkeratosis, 
P. acnes proliferation, and inflammation. An im-
mune response, including humoral and cellular 
immunity, and activation of complements develop 
to P. acnes. Recent studies have shown that P. 
acnes acts through TLRs, CD14 and CD1 re-
ceptors on keratinocytes, sebocytes and mac-
rophages, resulting in the production of multiple 
proinflammatory cytokines. All these factors cause 
development of comedones and progression into 
inflammed acne forms. Better understanding of 
these processes and trigger factors that induce 
their initiation is important for the improvement of 
this disease treatment. 
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